PLK1 and lung adenocarcinoma: These findings are consistent with previous results demonstrating that KDM1A inhibition attenuates the PLK1 mitotic pathway in lung adenocarcinoma [30] and suggest a role for KDM1A in regulating cell cycle progression through the regulation of the PLK1-AURKA axis and DDR.